Immunotargeting of liposomes to activated vascular endothelial cells: a strategy for site-selective delivery in the cardiovascular system
about
Vascular targeting of nanocarriers: perplexing aspects of the seemingly straightforward paradigmPSGL-1 derived from human neutrophils is a high-efficiency ligand for endothelium-expressed E-selectin under flowMicroparticle adhesive dynamics and rolling mediated by selectin-specific antibodies under flow.Action at a distance: lengthening adhesion bonds with poly(ethylene glycol) spacers enhances mechanically stressed affinity for improved vascular targeting of microparticlesTargeted delivery of therapeutics to endothelium.Reduction of BCNU toxicity to lung cells by high-level expression of O(6)-methylguanine-DNA methyltransferase.Inhibition of proinflammatory genes in anti-GBM glomerulonephritis by targeted dexamethasone-loaded AbEsel liposomes.Affinity manipulation of surface-conjugated RGD peptide to modulate binding of liposomes to activated platelets.Leukocyte-inspired biodegradable particles that selectively and avidly adhere to inflamed endothelium in vitro and in vivo.Targeting antioxidant and antithrombotic biotherapeutics to endothelium.Targeted modulation of reactive oxygen species in the vascular endotheliumInduction of inflammation in vascular endothelial cells by metal oxide nanoparticles: effect of particle composition.Endothelial targeting of antibody-decorated polymeric filomicelles.Vascular Accessibility of Endothelial Targeted Ferritin Nanoparticles.pH-sensitive liposomes--principle and application in cancer therapy.Antibody-targeted liposomes in cancer therapy and imaging.Vascular density and endothelial cell expression of integrin alpha v beta 3 and E-selectin in murine tumoursAdvanced drug delivery systems for antithrombotic agents.Streptavidin facilitates internalization and pulmonary targeting of an anti-endothelial cell antibody (platelet-endothelial cell adhesion molecule 1): a strategy for vascular immunotargeting of drugs.Recent advances in tumor vasculature targeting using liposomal drug delivery systems.Targeted siRNA delivery to diseased microvascular endothelial cells: cellular and molecular concepts.Dynamic factors controlling targeting nanocarriers to vascular endothelium.Targeting sites of inflammation: intercellular adhesion molecule-1 as a target for novel inflammatory therapies.Nanocarriers for vascular delivery of anti-inflammatory agentsEndothelial nanomedicine for the treatment of pulmonary disease.Delivery of c-myb antisense oligodeoxynucleotides to human neuroblastoma cells via disialoganglioside GD(2)-targeted immunoliposomes: antitumor effects.Targeted endothelial nanomedicine for common acute pathological conditions.Discovery of a potent nanoparticle P-selectin antagonist with anti-inflammatory effects in allergic airway disease.Recycling and LFA-1-dependent trafficking of ICAM-1 to the immunological synapse.A nonviral carrier for targeted gene delivery to tumor cells.Control of transgene expression using local hyperthermia in combination with a heat-sensitive promoter.Biodegradable nanoparticles mimicking platelet binding as a targeted and controlled drug delivery system.Improved Cryopreservation of Human Umbilical Vein Endothelial Cells: A Systematic ApproachLocal and average gloss from flat-faced sodium chloride tablets.Targeting of liposomes via PSGL1 for enhanced tumor accumulation.Modifications of microvascular EC surface modulate phototoxicity of a porphycene anti-ICAM-1 immunoconjugate; therapeutic implications.Limited adhesion of biodegradable microspheres to E- and P-selectin under flow.A proteasome inhibitor reduces concurrent, sequential, and long-term IL-1 beta- and TNF-alpha-induced ECAM expression and adhesion.Fourier transformed spectral bio-imaging for studying the intracellular fate of liposomes.Surface-functionalized nanoparticle library yields probes for apoptotic cells.
P2860
Q27026630-E9501114-9340-4750-8E77-CC7234BDA845Q28243799-BA40E150-5EF3-484A-8ED8-53FF6AF5D8E4Q30418235-C1BCF3B4-1781-4BED-BBE6-25A3B05B9A69Q30433477-F003FF81-9DE9-422C-9361-D177C3F239E0Q30475849-0F864A14-378D-40F8-B716-C841658746E1Q32128152-4504009F-1559-452A-872E-28D1FC65756FQ33312415-08D250CD-2E12-43B2-BA6A-30006EA95C90Q33314508-FAF3DC3B-ABC6-46FB-B85A-10DE01869079Q34792999-9F20FC47-8B96-4B57-8CA8-65E56F0AF82DQ34935960-E853DF89-64A7-49E6-8A04-9BE9501DB7C6Q35098774-93634474-0E2D-4F18-AB33-B8A4B78D7275Q35745065-C157D80C-6CCB-445D-95A1-D847D1E8FA1EQ35930068-5D67EB17-EF5A-4B23-9695-797360D9C17CQ36693096-313E4538-4DA0-41B2-BC87-7ED6F5A0D48CQ36790100-B1C55B43-2F73-47CC-9E9D-5F440CD4307AQ37076367-C7382853-4A30-418C-8147-BE8AED4BBDE4Q37096002-D2F928AD-60BA-4F40-A9D5-FF620A924278Q37132620-740FF365-5856-48DB-83A3-D0AF094EA94AQ37184666-22B4458E-C528-4541-8C7E-6FF3EAF100B2Q37603355-6FBF74B4-22F5-4592-9C68-BE3E645484E6Q37902117-4B084857-5B9E-421B-B742-A45AB8F5A076Q37980236-006F7935-59E3-4FDE-A50F-71BF17340EBDQ38151092-F00D80EE-AFFA-4BF0-BB39-86C76EA96DF3Q38176037-7C7D0C09-0DA9-4680-AF72-31FC39BFE18FQ38267984-C295FE3D-4E52-4D94-875B-F370E6D090AAQ38315868-00C515F8-ECA2-4788-95D3-D86030231C9DQ38598987-2EE6E5CE-129B-407A-A7F3-7DB312FAAAD4Q39656763-52F407D0-D3C9-44E4-84D5-A25D980EE3C8Q39672265-2C89D38C-70B3-4E0E-A2CB-E993C77D9EE0Q40603994-483789D1-6039-46E1-AEFC-04430147B366Q40880232-D61AB585-E190-4650-B7FC-4E4F3569A2DCQ40891191-82AB84D2-C41D-44F9-8E44-F3899781EED9Q41344641-E07DD762-7182-4235-B789-DD334C0280DCQ41990137-35149685-9746-48C3-9650-54B7FF03D42EQ42241201-BFA307AD-6AF2-41EB-9DE7-A7F6B7C70113Q42831090-CB8B57F0-C912-4976-B3D5-257D4C1CFFBFQ43602024-7B8BBEA4-F868-42D1-9E5A-4F9C1168F0FAQ44466963-0C6A7763-1CA8-461A-BA2E-4B9089512408Q44709519-8597EE0A-907B-491E-85CD-E59D9C7A2428Q44784403-959F9883-09A0-4949-8CB7-7254B45B21BA
P2860
Immunotargeting of liposomes to activated vascular endothelial cells: a strategy for site-selective delivery in the cardiovascular system
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Immunotargeting of liposomes t ...... y in the cardiovascular system
@ast
Immunotargeting of liposomes t ...... y in the cardiovascular system
@en
type
label
Immunotargeting of liposomes t ...... y in the cardiovascular system
@ast
Immunotargeting of liposomes t ...... y in the cardiovascular system
@en
prefLabel
Immunotargeting of liposomes t ...... y in the cardiovascular system
@ast
Immunotargeting of liposomes t ...... y in the cardiovascular system
@en
P2093
P2860
P356
P1476
Immunotargeting of liposomes t ...... y in the cardiovascular system
@en
P2093
C E Larsen
D D Spragg
D R Alford
G C Gurtner
M A Gimbrone
M I Cybulsky
R Greferath
P2860
P304
P356
10.1073/PNAS.94.16.8795
P407
P577
1997-08-01T00:00:00Z